Innate immune response induced by gene delivery vectors

International Journal of Pharmaceutics

Volumn 354, Issue 1-2, 2008, Pages 9-15

  Sakurai, Haruna ^a,b   Kawabata, Kenji ^a   Sakurai, Fuminori ^a   Nakagawa, Shinsaku ^b   Mizuguchi, Hiroyuki ^a,b  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Adenovirus vector; Innate immunity; Lipoplex

Indexed keywords

CHEMOKINE; CYTOKINE; LIPOPLEX; PLASMID DNA; VIRUS VECTOR;

ANTIGEN PRESENTING CELL; CELL MATURATION; CPG ISLAND; CYTOTOXICITY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE VECTOR; GENETIC DISORDER; GENETIC TRANSDUCTION; HUMAN; IN VIVO STUDY; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ADENOVIRIDAE; ANIMALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNITY, NATURAL; LIPOSOMES; PLASMIDS;

EID: 40849104849     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.06.012     Document Type: Short Survey

References (75)

1. Basner-Tschakarjan E., Gaffal E., O'Keeffe M., Tormo D., Limmer A., Wagner H., Hochrein H., and Tuting T. Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production. J. Gene. Med. 8 (2006) 1300-1306
2. Bolesta E., Kowalczyk A., Wierzbicki A., Eppolito C., Kaneko Y., Takiguchi M., Stamatatos L., Shrikant P.A., and Kozbor D. Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery. J. Immunol. 177 (2006) 177-191
3. Borgland S.L., Bowen G.P., Wong N.C., Libermann T.A., and Muruve D.A. Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB. J. Virol. 74 (2000) 3941-3947
4. Bowen G.P., Borgland S.L., Lam M., Libermann T.A., Wong N.C., and Muruve D.A. Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappaB. Hum. Gene. Ther. 13 (2002) 367-379
5. Bruder J.T., and Kovesdi I. Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J. Virol. 71 (1997) 398-404
6. Colonna M., Trinchieri G., and Liu Y.J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5 (2004) 1219-1226
7. De Geest B., Snoeys J., Van Linthout S., Lievens J., and Collen D. Elimination of innate immune responses and liver inflammation by PEGylation of adenoviral vectors and methylprednisolone. Hum. Gene. Ther. 16 (2005) 1439-1451
8. Farina S.F., Gao G.P., Xiang Z.Q., Rux J.J., Burnett R.M., Alvira M.R., Marsh J., Ertl H.C., and Wilson J.M. Replication-defective vector based on a chimpanzee adenovirus. J. Virol. 75 (2001) 11603-11613
9. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Ringold G.M., and Danielsen M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 7413-7417
10. Felgner P.L., Tsai Y.J., Sukhu L., Wheeler C.J., Manthorpe M., Marshall J., and Cheng S.H. Improved cationic lipid formulations for in vivo gene therapy. Ann. NY Acad. Sci. 772 (1995) 126-139
11. Gautam A., Densmore C.L., and Waldrep J.C. Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy. Gene. Ther. 8 (2001) 254-257
12. Hartman Z.C., Black E.P., and Amalfitano A. Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cells. Virology 358 (2007) 357-372
13. Hartman Z.C., Kiang A., Everett R.S., Serra D., Yang X.Y., Clay T.M., and Amalfitano A. Adenovirus infection triggers a rapid, MyD88 regulated, transcriptome response critical to acute phase and adaptive immune responses in vivo. J. Virol. 81 (2007) 1796-1812
14. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
15. Higuchi Y., Kawakami S., Nishikawa M., Yamashita F., and Hashida M. Intracellular distribution of NFkappaB decoy and its inhibitory effect on TNFalpha production by LPS stimulated RAW 264.7 cells. J. Control. Release 107 (2005) 373-382
16. Higuchi Y., Kawakami S., Oka M., Yamashita F., and Hashida M. Suppression of TNFalpha production in LPS induced liver failure in mice after intravenous injection of cationic liposomes/NFkappaB decoy complex. Pharmazie 61 (2006) 144-147
17. Holterman L., Vogels R., van der Vlugt R., Sieuwerts M., Grimbergen J., Kaspers J., Geelen E., van der Helm E., Lemckert A., Gillissen G., Verhaagh S., Custers J., Zuijdgeest D., Berkhout B., Bakker M., Quax P., Goudsmit J., and Havenga M. Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5. J. Virol. 78 (2004) 13207-13215
18. Ishii K.J., Coban C., Kato H., Takahashi K., Torii Y., Takeshita F., Ludwig H., Sutter G., Suzuki K., Hemmi H., Sato S., Yamamoto M., Uematsu S., Kawai T., Takeuchi O., and Akira S. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7 (2006) 40-48
19. Johansson C., Jonsson M., Marttila M., Persson D., Fan X., Skog J., Frangsmyr L., Wadell G., and Arnberg N. Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells. J. Virol 81 (2007) 954-963
20. Kawai T., and Akira S. Innate immune recognition of viral infection. Nat. Immunol. 7 (2006) 131-137
21. Kiang A., Hartman Z.C., Everett R.S., Serra D., Jiang H., Frank M.M., and Amalfitano A. Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system. Mol. Ther. 14 (2006) 588-598
22. Koizumi N., Mizuguchi H., Sakurai F., Yamaguchi T., Watanabe Y., and Hayakawa T. Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation. J. Virol. 77 (2003) 13062-13072
23. Koizumi N., Kawabata K., Sakurai F., Watanabe Y., Hayakawa T., and Mizuguchi H. Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity. Hum. Gene. Ther. 17 (2006) 264-279
24. Koizumi N., Yamaguchi T., Kawabata K., Sakurai F.T.S., Watanabe Y., Hayakawa T., and Mizuguchi H. Fiber-modified adenovirus vectors decrease liver toxicity through reduced interleukin 6 production. J. Immunol. 178 (2007) 1767-1773
25. Kuramoto T., Nishikawa M., Thanaketpaisarn O., Okabe T., Yamashita F., and Hashida M. Use of lipoplex-induced nuclear factor-kappaB activation to enhance transgene expression by lipoplex in mouse lung. J. Gene. Med. 8 (2006) 53-62
26. Li S., Wu S.P., Whitmore M., Loeffert E.J., Wang L., Watkins S.C., Pitt B.R., and Huang L. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. Am. J. Physiol. 276 (1999) L796-L804
27. Lieber A., He C.Y., Meuse L., Schowalter D., Kirillova I., Winther B., and Kay M.A. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J. Virol. 71 (1997) 8798-8807
28. Liu F., and Huang L. Development of non-viral vectors for systemic gene delivery. J. Control. Release. 78 (2002) 259-266
29. Liu F., Shollenberger L.M., and Huang L. Non-immunostimulatory nonviral vectors. FASEB J. 18 (2004) 1779-1781
30. Liu Q., Zaiss A.K., Colarusso P., Patel K., Haljan G., Wickham T.J., and Muruve D.A. The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors. Hum. Gene. Ther. 14 (2003) 627-643
31. Liu Q., White L.R., Clark S.A., Heffner D.J., Winston B.W., Tibbles L.A., and Muruve D.A. Akt/protein kinase B activation by adenovirus vectors contributes to NFkappaB-dependent CXCL10 expression. J. Virol. 79 (2005) 14507-14515
32. Liu Y., Liggitt D., Zhong W., Tu G., Gaensler K., and Debs R. Cationic liposome-mediated intravenous gene delivery. J. Biol. Chem. 270 (1995) 24864-24870
33. Loisel S., Le Gall C., Doucet L., Ferec C., and Floch V. Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum. Gene. Ther. 12 (2001) 685-696
34. Manickan E., Smith J.S., Tian J., Eggerman T.L., Lozier J.N., Muller J., and Byrnes A.P. Rapid Kupffer cell death after intravenous injection of adenovirus vectors. Mol. Ther. 13 (2006) 108-117
35. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 286 (1999) 2244-2245
36. Mizuguchi H., and Hayakawa T. Targeted adenovirus vectors. Hum. Gene. Ther. 15 (2004) 1034-1044
37. Morelli A.E., Larregina A.T., Ganster R.W., Zahorchak A.F., Plowey J.M., Takayama T., Logar A.J., Robbins P.D., Falo L.D., and Thomson A.W. Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J. Virol. 74 (2000) 9617-9628
38. Muruve D.A. The innate immune response to adenovirus vectors. Hum. Gene. Ther. 15 (2004) 1157-1166
39. Muruve D.A., Barnes M.J., Stillman I.E., and Liberman T.A. Adenoviral gene delivery leads to rapid induction of multiple chemokines and acute neutrophil dependent hepatic injury in vivo. Hum. Gen. Ther. 10 (1999) 965-976
40. Ni, S., Gaggar, A., Paolo, N.D., Li, Z., Liu, Y., Strauss, R., Sova, P., Morihara, J., Feng, Q., Kiviat, N., Toure, P., Sow, P., Lieber, A., in press. Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting. Cancer Gene. Ther.
41. Niidome T., and Huang L. Gene therapy progress and prospects: nonviral vectors. Gene. Ther. 9 (2002) 1647-1652
42. Palmer D.J., and Ng P. Helper-dependent adenoviral vectors for gene therapy. Hum. Gene. Ther. 16 (2005) 1-16
43. Parker A.L., Waddington S.N., Nicol C.G., Shayakhmetov D.M., Buckley S.M., Denby L., Kemball-Cook G., Ni S., Lieber A., McVey J.H., Nicklin S.A., and Baker A.H. Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 108 (2006) 2554-2561
44. Prud'homme G.J. DNA vaccination against tumors. J. Gene. Med. 7 (2005) 3-17
45. Qin L., Ding Y., Pahud D.R., Chang E., Imperiale M.J., and Bromberg J.S. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum. Gene. Ther. 8 (1997) 2019-2029
46. Raper S.E., Chirmule N., Lee F.S., Wivel N.A., Bagg A., Gao G.P., Wilson J.M., and Batshaw M.L. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80 (2003) 148-158
47. Roberts D.M., Nanda A., Havenga M.J., Abbink P., Lynch D.M., Ewald B.A., Liu J., Thorner A.R., Swanson P.E., Gorgone D.A., Lifton M.A., Lemckert A.A., Holterman L., Chen B., Dilraj A., Carville A., Mansfield K.G., Goudsmit J., and Barouch D.H. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature 441 (2006) 239-243
48. Sakurai F., Terada T., Yasuda K., Yamashita F., Takakura Y., and Hashida M. The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes. Gene. Ther. 9 (2002) 1120-1126
49. Sakurai F., Mizuguchi H., and Hayakawa T. Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector. Gene. Ther. 10 (2003) 1041-1048
50. Sakurai F., Terada T., Maruyama M., Watanabe Y., Yamashita F., Takakura Y., and Hashida M. Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model. Cancer Gene. Ther. 10 (2003) 661-668
51. Sakurai H., Sakurai F., Kawabata K., Sasaki T., Koizumi N., Huang H., Tashiro K., Kurachi S., Nakagawa S., and Mizuguchi H. Comparison of gene expression efficiency and innate immune response induced by Ad vector and lipoplex. J. Control. Release. 117 (2007) 430-437
52. Scheule R.K. The role of CpG motifs in immunostimulation and gene therapy. Adv. Drug Deliv. Rev. 44 (2000) 119-134
53. Schnell M.A., Zhang Y., Tazelaar J., Gao G.P., Yu Q.C., Qian R., Chen S.J., Varnavski A.N., LeClair C., Raper S.E., and Wilson J.M. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol. Ther. 3 (2001) 708-722
54. Schoggins J.W., Nociari M., Philpott N., and Falck-Pedersen E. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation. J. Virol. 79 (2005) 11627-11637
55. Sellins K., Fradkin L., Liggitt D., and Dow S. Type I interferons potently suppress gene expression following gene delivery using liposome(-)DNA complexes. Mol. Ther. 12 (2005) 451-459
56. Seshidhar Reddy P., Ganesh S., Limbach M.P., Brann T., Pinkstaff A., Kaloss M., Kaleko M., and Connelly S. Development of adenovirus serotype 35 as a gene transfer vector. Virology 311 (2003) 384-393
57. Shayakhmetov D.M., Li Z.Y., Ni S., and Lieber A. Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors. J. Virol. 78 (2004) 5368-5381
58. Shayakhmetov D.M., Gaggar A., Ni S., Li Z.Y., and Lieber A. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J. Virol. 79 (2005) 7478-7491
59. Shenk T.E. In: Howley D.M.Ka.P.M. (Ed). Adenoviridae: The Viruses and their Replication vol. 2 (2001), Lippincott Williams & Wilkins, Philadelphia 2265-2300
60. Suomalainen M., Nakano M.Y., Boucke K., Keller S., and Greber U.F. Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. EMBO J. 20 (2001) 1310-1319
61. Tamanini A., Nicolis E., Bonizzato A., Bezzerri V., Melotti P., Assael B.M., and Cabrini G. Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells. J. Virol. 80 (2006) 11241-11254
62. Tibbles L.A., Spurrell J.C., Bowen G.P., Liu Q., Lam M., Zaiss A.K., Robbins S.M., Hollenberg M.D., Wickham T.J., and Muruve D.A. Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10. J. Virol. 76 (2002) 1559-1568
63. Vogels R., Zuijdgeest D., van Rijnsoever R., Hartkoorn E., Damen I., de Bethune M.P., Kostense S., Penders G., Helmus N., Koudstaal W., Cecchini M., Wetterwald A., Sprangers M., Lemckert A., Ophorst O., Koel B., van Meerendonk M., Quax P., Panitti L., Grimbergen J., Bout A., Goudsmit J., and Havenga M. Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J. Virol. 77 (2003) 8263-8271
64. Whitmore M., Li S., and Huang L. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene. Ther. 6 (1999) 1867-1875
65. Wilson J.M. Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334 (1996) 1185-1187
66. Xu Z.L., Mizuguchi H., Sakurai F., Koizumi N., Hosono T., Kawabata K., Watanabe Y., Yamaguchi T., and Hayakawa T. Approaches to improving the kinetics of adenovirus-delivered genes and gene products. Adv. Drug Deliv. Rev. 57 (2005) 781-802
67. Yamaguchi, T., Kawabata, K., Koizumi, N., Sakurai, F., Nakashima, K., Sasaki, T., Okada, N., Mizuguchi, H., in press. Involvement of MyD88 and TLR9 in the innate immune response elicited by replication-incompetent adenovirus vectors. Hum. Gene. Ther.
68. Yang Y., Ertl H.C., and Wilson J.M. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1 (1994) 433-442
69. Yang Y., Li Q., Ertl H.C., and Wilson J.M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69 (1995) 2004-2015
70. Yasuda K., Ogawa Y., Yamane I., Nishikawa M., and Takakura Y. Macrophage activation by a DNA/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways. J. Leukoc. Biol. 77 (2005) 71-79
71. Yoneyama H., Matsuno K., Zhang Y., Nishiwaki T., Kitabatake M., Ueha S., Narumi S., Morikawa S., Ezaki T., Lu B., Gerard C., Ishikawa S., and Matsushima K. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int. Immunol. 16 (2004) 915-928
72. Yoneyama H., Matsuno K., Toda E., Nishiwaki T., Matsuo N., Nakano A., Narumi S., Lu B., Gerard C., Ishikawa S., and Matsushima K. Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J. Exp. Med. 202 (2005) 425-435
73. Zhang Y., Chirmule N., Gao G.P., Qian R., Croyle M., Joshi B., Tazelaar J., and Wilson J.M. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol. Ther. 3 (2001) 697-707
74. Zhao H., Hemmi H., Akira S., Cheng S.H., Scheule R.K., and Yew N.S. Contribution of Toll-like receptor 9 signaling to the acute inflammatory response to nonviral vectors. Mol. Ther. 9 (2004) 241-248
75. Zhu N., Liggitt D., Liu Y., and Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science 261 (1993) 209-211